Dental AI Diagnostics and the FDA: What’s Actually Cleared and What’s Just Marketing
Dental AI seems to be everywhere—claiming to “detect everything,” “eliminate missed caries,” and “guarantee accurate diagnoses.” Between the buzzwords and bold promises, many dental teams are asking a basic question: what has the FDA actually cleared, and what’s just creative marketing wrapped in tech talk?
Understanding the difference matters for clinical decision‑making, documentation, and risk.
What the FDA Actually Regulates in Dental AI
The FDA doesn’t regulate “AI” as a buzzword. It regulates medical devices—including software—based on what they claim to do. If a product analyzes radiographs to assist in detecting pathology, it’s usually considered a medical device and needs clearance or approval before being marketed for that clinical use.
Most dental AI tools on the market today fall into the category of “computer‑aided detection/diagnosis” (CADe/CADx). Their cleared indications often sound like:
- “Assist clinicians in detecting and outlining suspected carious lesions or periapical radiolucencies on dental radiographs.”
- “Highlight regions of interest for further review; final diagnosis rests with the clinician.”
Notice the language: assist, highlight, support. FDA‑cleared AI does not replace professional judgment; it augments it. If a company implies their AI can diagnose independently or “read X‑rays better than dentists,” that’s a red flag to look closely at what their actual FDA clearance says.
Reading Between the Lines of AI Marketing
Many products in dentistry use AI or machine learning on the back end but don’t make regulated diagnostic claims. They may say they “optimize workflows,” “predict production,” or “analyze patient behavior.” Those uses can be valuable, but they’re not the same as FDA‑cleared clinical diagnostics.
Where confusion—and risk—creeps in is when marketing stretches beyond the cleared indication:
- A tool cleared to highlight potential lesions is pitched as definitively diagnosing caries.
- AI that compares bone levels over time is framed as “automatically staging periodontal disease.”
- Radiographic aid software is sold as proof that you must treat a specific tooth, now.
If you are relying on an AI output as a deciding factor rather than an input to your own diagnostic process, you may be using it beyond its intended use—and stepping into uncomfortable medicolegal territory if outcomes are challenged.
Practical Steps for Dental Teams
Before adopting or relying heavily on dental AI, pull the conversation out of the sales demo and into the regulatory reality:
- Ask for the FDA 510(k) number and read the official “Indications for Use.” That’s the legally binding description of what the software is cleared to do.
- Confirm whether the AI is classified as diagnostic support (highlighting, measuring, comparing) versus providing an autonomous diagnosis. The former is what’s typically cleared in dentistry today.
- Make sure your documentation reflects that you made the diagnosis. If AI highlighting influenced your thinking, that’s fine—but the record should still read like a clinician driven by evidence, not a software output.
Finally, talk openly with your team about AI’s role. It can improve consistency, catch overlooked findings, and support patient education. But it does not remove the need for careful interpretation, informed consent, and professional accountability.
The bottom line: FDA‑cleared dental AI is real and increasingly useful—but narrower and more modest than many marketing claims suggest. Knowing exactly what’s cleared, and using it within those bounds, is how you get the benefits of AI without handing your clinical judgment—and your liability—to a sales brochure.
*****
Looking for OSHA and HIPAA CE Training? MyDentalCE keeps CE courses flexible and affordable.